Market revenue in 2023 | USD 1,120.6 million |
Market revenue in 2030 | USD 1,584.1 million |
Growth rate | 5.1% (CAGR from 2023 to 2030) |
Largest segment | Attenuated vaccine |
Fastest growing segment | DNA Vaccines |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Attenuated Vaccine, Inactivated Vaccine, Subunit Vaccines, Toxoid Vaccines, DNA Vaccines |
Key market players worldwide | Lonza Group Ltd, FUJIFILM Holdings Corp, Merck KGaA, Catalent Inc, Icon PLC, Syngene, Curia, Ajinomoto Co Inc, IDT Biologika |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to vaccine contract manufacturing market will help companies and investors design strategic landscapes.
Attenuated vaccine was the largest segment with a revenue share of 29.98% in 2023. Horizon Databook has segmented the U.S. vaccine contract manufacturing market based on attenuated vaccine, inactivated vaccine, subunit vaccines, toxoid vaccines, dna vaccines covering the revenue growth of each sub-segment from 2018 to 2030.
The U.S. is the largest market for vaccine contract manufacturing in 2023. Steady growth of the U.S. pharmaceutical industry, as well as increased outsourcing for pharmaceutical development by large pharma companies, has resulted in the dominant share of this country.
Furthermore, the U.S. is recognized as the largest biopharmaceutical market with respect to biopharmaceutical manufacturing & sales, in addition to the local presence of biomanufacturing facilities. According to the Pharmaceutical Research and Manufacturers Association (PhRMA), the majority of pharmaceutical R&D is being conducted in this country.
In addition, factors such as the free-pricing pharmaceuticals market, high prevalence of chronic illnesses, large geriatric population, and high per capita income are expected to contribute to the dominance of the U.S. in this region throughout the forecast period.
Horizon Databook provides a detailed overview of country-level data and insights on the U.S. vaccine contract manufacturing market , including forecasts for subscribers. This country databook contains high-level insights into U.S. vaccine contract manufacturing market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account